Through a comprehensive analysis of the TIME using our model, we identified metabolic reprogramming as the most prominent alteration driving tumor evolution, characterized by the opposing shifts in glucose metabolism observed between tumor cells and CD8+ T cells. This evidence concerns the gene CD8A and neoplasm.